Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2013


Phase I & IIA clinical trials

27 Feb 2013 - 28 Feb 2013 - London, UK



Bookmark and Share


The Phase I & IIa Clinical Trials conference has been revamped for 2013 to provide you with two highly focused and high quality streams, providing answers to the latest questions in early phase drug development. This year we will be looking at how we can design more effective and efficient Phase I & IIa clinical trials, benchmarking against current industry models to find out what works best and how we can adapt this to our trials going forward.

6 Reasons why you MUST attend this conference……

Over 160 attendees from small, medium and large pharma and biotech companies 

Wine Casino networking event - your opportunity to meet new faces in early phase clinical development 

8 interactive sessions: Don’t miss our regulatory Q&A to get the latest updates on EU and US regulations and find out how you can remain compliant 

70 speakers including 6 Vice Presidents, 10 Heads and 15 Directors from pharma and 10 CEOs and CMOs from biotech 

Increased focus on biotech  - with speakers from 13 leading biotech companies 

2 re-engineered streams including one stream entirely dedicated to outsourcing and patient recruitment in early phase trials 

Please quote CQ4170TN when booking your place.

For more information and to download the conference brochure, please visit: 

http://www.informa-ls.com/CQ4170TN




Further information
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Gene Regulation in Brain May Explain Repetitive Behaviors in Rett Syndrome Patients
The research could be a key step in developing treatments to eliminate symptoms that drastically impair the quality of life in Rett patients.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Iron Nanoparticles Make Immune Cells Attack Cancer
Researchers accidentally discover that nanoparticles invented for anemia treatment can trigger the immune system’s ability to destroy tumor cells.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Uncovering Cancer’s ‘Invisibility Cloak’
Researchers discover cancer cell mechanism to become invisible to the body's immune system.
Genetic Impact of Endurance Training
Research has found that endurance training changes genetic activity in thousands of genes, giving rise to large number of altered RNA variants.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!